Cargando…
Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
There is a pressing need to develop new antiviral treatments; of the 60 drugs currently available, half are aimed at HIV-1 and the remainder target only a further six viruses. This demand has led to the emergence of possible peptide therapies, with 15 currently in clinical trials. Advancements in un...
Autores principales: | Gwyer Findlay, Emily, Currie, Silke M., Davidson, Donald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775153/ https://www.ncbi.nlm.nih.gov/pubmed/23649937 http://dx.doi.org/10.1007/s40259-013-0039-0 |
Ejemplares similares
-
Antiviral Host Defence Peptides
por: Sousa, Filipa Henderson, et al.
Publicado: (2016) -
Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo
por: Beaumont, Paula E., et al.
Publicado: (2014) -
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
por: Currie, Silke M., et al.
Publicado: (2013) -
Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans
por: Currie, Silke M., et al.
Publicado: (2016) -
Therapeutic Approaches Using Host Defence Peptides to Tackle Herpes Virus Infections
por: Jenssen, Håvard
Publicado: (2009)